TrialAIDS (London, England)2026

Baseline and week 48 resistance analysis in participants receiving bictegravir + lenacapavir in the phase 2 ARTISTRY-1 study.

Nina Pennetzdorfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.